title: Biological agents: new drugs, old problems.
authors.forename: Rosa
authors.initials: R
authors.lastname: Muñoz-Cano
authors.forename: Jerónimo
authors.initials: J
authors.lastname: Carnés
authors.forename: Jaime
authors.initials: J
authors.lastname: Sanchez-Lopez
authors.forename: Albert
authors.initials: A
authors.lastname: Saiz
authors.forename: Joan
authors.initials: J
authors.lastname: Bartra
authors.forename: M Angeles
authors.initials: MA
authors.lastname: Lopez-Matas
authors.forename: Cesar
authors.initials: C
authors.lastname: Picado
authors.forename: Antonio
authors.initials: A
authors.lastname: Valero
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology / Q000493:pharmacokinetics; D061067:Antibodies, Monoclonal, Humanized; D004342:Drug Hypersensitivity / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006633:Histamine Antagonists / Q000008:administration & dosage*; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D000069442:Natalizumab; D012882:Skin Tests
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006633:Histamine Antagonists; D000069442:Natalizumab